相关实验视频
Updated: May 27, 2025

07:24
Home-Based Monitor for Gait and Activity Analysis
Published on: August 8, 2019
6.7K
遗传神经肌肉疾病遗传疗法的胜利,试验和未来考虑
W David Arnold1, Kajri Majithia2
1Executive Director of NextGen Precision Health, and in the Department of Physical Medicine and Rehabilitation, University of Missouri-Columbia, Columbia, Missouri.
Missouri medicine
|February 17, 2025
概括
基因疗法正在推进神经肌肉疾病,如脊柱肌肉缩和杜申肌肉衰竭. 本综述涵盖了这些疾病的精准医学当前进展,挑战和未来方向.
科学领域:
- 神经学 神经学
- 遗传学 遗传学 是一个
- 精准医学是一门精准的医学.
背景情况:
- 神经肌肉疾病影响运动神经元,神经,结节和肌肉,源于获得或遗传因素.
- 最近,遗传性神经肌肉疾病的基因疗法显著增加.
研究的目的:
- 在精准医学背景下,审查神经肌肉疾病遗传疗法的现状.
- 确定该领域的成就和剩余的挑战.
- 专注于脊柱肌肉缩,杜申肌肉发育不良和肌缩侧面硬化症的进展.
主要方法:
- 关于神经肌肉疾病遗传疗法的最新进展的文献综述.
- 对这些疗法应用的精准医学框架的分析.
- 讨论具体的案例研究,包括脊髓肌缩,杜申肌缩和肌缩侧面硬化症.
主要成果:
- 基因疗法已经显示出希望,特别是在特定的遗传神经肌肉疾病.
- 在脊髓肌肉缩,杜申肌肉发育不良和骨髓缩侧面硬化症方面取得了显著进展.
- 在治疗可访问性,长期疗效和广泛适用性方面仍然存在差距.
结论:
- 精准医学对于将基因疗法定制为个体神经肌肉疾病患者至关重要.
- 需要继续进行研究和开发,以克服当前的局限性并改善患者的治疗结果.
- 未来的战略应该集中在加速下一代疗法和提高其有效性.
相关概念视频
Gene Therapy
25.1K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.1K
Myasthenia Gravis: Overview and Treatment
1.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.1K
Satellite Stem Cells and Muscular Dystrophy
1.9K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
1.9K
What is Genetic Engineering?
73.3K
Overview
73.3K
X-linked Traits
53.0K
In most mammalian species, females have two X sex chromosomes and males have an X and Y. As a result, mutations on the X chromosome in females may be masked by the presence of a normal allele on the second X. In contrast, a mutation on the X chromosome in males more often causes observable biological defects, as there is no normal X to compensate. Trait variations arising from mutations on the X chromosome are called “X-linked”.
53.0K
Myasthenia Gravis: Diagnostic Tests
601
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
601

